In addition, a meta-analysis by Sun et al. (2020) reported that the RNF213 rs112735431 variant—associated with ICAD and moyamoya disease—conferred a slightly lower risk in Chinese populations compared to Japanese and Korean populations, suggesting possible genetic differences in ICAD susceptibility among East Asians. This evidence concerns the gene RNF213 and Moyamoya disease.